These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10899401)

  • 1. Alpha-synuclein immunoreactivity of huntingtin polyglutamine aggregates in striatum and cortex of Huntington's disease patients and transgenic mouse models.
    Charles V; Mezey E; Reddy PH; Dehejia A; Young TA; Polymeropoulos MH; Brownstein MJ; Tagle DA
    Neurosci Lett; 2000 Jul; 289(1):29-32. PubMed ID: 10899401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huntington aggregates may not predict neuronal death in Huntington's disease.
    Kuemmerle S; Gutekunst CA; Klein AM; Li XJ; Li SH; Beal MF; Hersch SM; Ferrante RJ
    Ann Neurol; 1999 Dec; 46(6):842-9. PubMed ID: 10589536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity.
    Jana NR; Tanaka M; Wang Gh; Nukina N
    Hum Mol Genet; 2000 Aug; 9(13):2009-18. PubMed ID: 10942430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huntingtin localization in brains of normal and Huntington's disease patients.
    Sapp E; Schwarz C; Chase K; Bhide PG; Young AB; Penney J; Vonsattel JP; Aronin N; DiFiglia M
    Ann Neurol; 1997 Oct; 42(4):604-12. PubMed ID: 9382472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.
    Sieradzan KA; Mechan AO; Jones L; Wanker EE; Nukina N; Mann DM
    Exp Neurol; 1999 Mar; 156(1):92-9. PubMed ID: 10192780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release.
    Jana NR; Zemskov EA; Wang Gh ; Nukina N
    Hum Mol Genet; 2001 May; 10(10):1049-59. PubMed ID: 11331615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
    DiFiglia M; Sapp E; Chase KO; Davies SW; Bates GP; Vonsattel JP; Aronin N
    Science; 1997 Sep; 277(5334):1990-3. PubMed ID: 9302293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.
    Weiss A; Klein C; Woodman B; Sathasivam K; Bibel M; Régulier E; Bates GP; Paganetti P
    J Neurochem; 2008 Feb; 104(3):846-58. PubMed ID: 17986219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical, ultrastructural, and reversibility studies on huntingtin filaments isolated from mouse and human brain.
    Díaz-Hernández M; Moreno-Herrero F; Gómez-Ramos P; Morán MA; Ferrer I; Baró AM; Avila J; Hernández F; Lucas JJ
    J Neurosci; 2004 Oct; 24(42):9361-71. PubMed ID: 15496672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice.
    Li H; Li SH; Yu ZX; Shelbourne P; Li XJ
    J Neurosci; 2001 Nov; 21(21):8473-81. PubMed ID: 11606636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis.
    Lee CY; Cantle JP; Yang XW
    FEBS J; 2013 Sep; 280(18):4382-94. PubMed ID: 23829302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired glutamate uptake in the R6 Huntington's disease transgenic mice.
    Liévens JC; Woodman B; Mahal A; Spasic-Boscovic O; Samuel D; Kerkerian-Le Goff L; Bates GP
    Neurobiol Dis; 2001 Oct; 8(5):807-21. PubMed ID: 11592850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Synuclein levels modulate Huntington's disease in mice.
    Corrochano S; Renna M; Carter S; Chrobot N; Kent R; Stewart M; Cooper J; Brown SD; Rubinsztein DC; Acevedo-Arozena A
    Hum Mol Genet; 2012 Feb; 21(3):485-94. PubMed ID: 22010050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice.
    Yu ZX; Li SH; Nguyen HP; Li XJ
    Hum Mol Genet; 2002 Apr; 11(8):905-14. PubMed ID: 11971872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
    Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
    Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue transglutaminase selectively modifies proteins associated with truncated mutant huntingtin in intact cells.
    Chun W; Lesort M; Tucholski J; Faber PW; MacDonald ME; Ross CA; Johnson GV
    Neurobiol Dis; 2001 Jun; 8(3):391-404. PubMed ID: 11442349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.
    Huang CC; Faber PW; Persichetti F; Mittal V; Vonsattel JP; MacDonald ME; Gusella JF
    Somat Cell Mol Genet; 1998 Jul; 24(4):217-33. PubMed ID: 10410676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease.
    Tomás-Zapico C; Díez-Zaera M; Ferrer I; Gómez-Ramos P; Morán MA; Miras-Portugal MT; Díaz-Hernández M; Lucas JJ
    Hum Mol Genet; 2012 Feb; 21(3):495-510. PubMed ID: 22045698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.